The risk of developing VITT is small (1 case per 26 500 to 127,300 after the first vaccine dose 7 ), while the risk of COVID-19 infection is still highly significant worldwide, having caused millions of deaths and huge morbidity, and social economic damage around the globe.
← all excerpts
NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia.
1
—
—